Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 1
1984 1
1985 5
1986 5
1987 2
1988 12
1989 3
1990 11
1991 14
1992 11
1993 11
1994 16
1995 22
1996 30
1997 34
1998 52
1999 38
2000 49
2001 47
2002 65
2003 81
2004 62
2005 112
2006 124
2007 101
2008 137
2009 165
2010 217
2011 241
2012 269
2013 349
2014 375
2015 462
2016 505
2017 641
2018 703
2019 843
2020 1003
2021 1144
2022 1346
2023 1415
2024 1659
2025 1854
2026 1176

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,766 results

Results by year

Filters applied: . Clear all
Page 1
Oxetane-to-azetidine skeletal editing.
Tian D, Luo L, Xiao X, Chen G, Zhang L, Wang J, Wang X, Zhang HJ. Tian D, et al. Among authors: luo l. Nat Chem. 2026 Jul 13. doi: 10.1038/s41557-026-02213-7. Online ahead of print. Nat Chem. 2026. PMID: 42443628
A RIG-I targeting nanozyme induces PANoptosis for cancer immunotherapy.
Dong S, Yuan Y, Cao H, Zhang M, Liang S, Zhang M, Su X, Luo L, Zhao X, Li L, Xu Q, Li Y, Guo K, Guo X, Shi J, Gao L, Zhang G, Hu S, Chen L. Dong S, et al. Among authors: luo l. Nat Commun. 2026 May 11;17(1):6311. doi: 10.1038/s41467-026-72973-w. Nat Commun. 2026. PMID: 42115183 Free article.
Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.
Alsaleh G, Ali M, Kayvanjoo AH, Liu F, Moreau T, Bibi S, Luo L, Govender M, Carroll M, Hofer SJ, Tobias E, Magnes C, Kell L, Chung C, Deng Y, Bhandari A, Garner LC, Conrad T, Chen L, Kronsteiner-Dobramysl B, Dunachie S, Spiller OB, Lambe T, Klenerman P, Jones LC, Simon AK. Alsaleh G, et al. Among authors: luo l. Aging Cell. 2026 Jun;25(6):e70545. doi: 10.1111/acel.70545. Aging Cell. 2026. PMID: 42169618 Free PMC article. Clinical Trial.
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.
Naji NS, Ahmedna TS, Zeng X, An Y, Hemani Y, Perkins B, Thompson Z, Nichakawade TD, Wang Y, Lee BS, Watson E, Chatzilygeroudi T, Luo LZ, Paun B, Klausner M, Supeanu TD, Gojo I, Ghiaur G, DeZern AE, Levis MJ, Resar LMS, Jones RJ, Peske JD, Karanika S, Paul S, Karantanos T. Naji NS, et al. Among authors: luo lz. Blood Adv. 2026 May 20:bloodadvances.2025019380. doi: 10.1182/bloodadvances.2025019380. Online ahead of print. Blood Adv. 2026. PMID: 42160756
13,766 results
You have reached the last available page of results. Please see the User Guide for more information.